La cadena de opciones muestra datos clave de las opciones de acciones de Permian Resources a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Permian Resources..

Permian Resources (NYSE:PR) Bolsa, Cadena de Opciones

Permian Resources

Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.

Equities

Large Cap

News

FTXN

OILT

Las acciones de Occidental Petroleum caen tras la compra de CrownRock por 12.000 millones de dólares. ¿Qué implica esta adquisición?

¿Qué está sucediendo con las acciones de Occidental Petroleum el viernes?

Permian Resources Corporation Class A Common Stock

Permian Resources Corp

ProAssurance Corp

PRA Group Inc

PRODUCTIVITY TECHS CORP by Productivity Technologies Corp.

Productivity Technologies Corp

Northern Lights Fund Trust III PlanRock Alternative Growth ETF

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicines Inc

NEOS ETF Trust FIS Christian Stock Fund

PRECISE BIOMETRICS AB by Precise Biometrics AB

Precise Biometrics AB

Parabellum Acquisition Corp Class A

Parabellum Acquisition Corp Units (1 Ord Share Class A & 3/4 War)

Parabellum Acquisition Corp Warrants(01/01/9999)

PREMIUM BRANDS HOLDINGS by Premium Brands Holding Corp.

Premium Brands Holdings Corp

PROTEIN REACTOR COMBINED by Protein Reactor Combined Fuels Inc

Protein Reactor Combined Fuels Inc

Porch Group Inc

PLACER CREEK MINING CO by Placer Creek Mining Co.

Placer Creek Mining Co

Parcl - United States Dollar

PURE GLOBAL CANNABIS INC by Pure Global Cannabis Inc.

Pure Global Cannabis Inc

Procurri Corp Ltd

Parnassus Income Funds Parnassus Core Select ETF

PROCEPT BioRobotics Corporation - Common Stock

PROCEPT BioRobotics Corp

Procaps Group SA

PHOENIX RISING COS by PHOENIX RISING COS.

Phoenix Rising Co

GREEN CROSS HLTH LTD by Green Cross Health Ltd

Green Cross Health Ltd

Premier Diversified Holdings Inc

PARADOX INTERACTIVE U/ADR by Paradox Interactive AB

Paradox Interactive AB

PROFITABLE DEVELOPMENTS by Profitable Developments, Inc.

Profitable Developments Inc

Perdoceo Education Corporation - Common Stock

Perdoceo Education Corp

PARDES BIOSCIENCES INC COM

Prada SpA

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global Ltd

Presearch

PRESTIGE CARS INTL by Prestige Cars International, Inc.

Prestige Cars International Inc

Predictive Technology Group Inc

PREDICTIVE TECH GROUP INC by Predictive Technology Group, Inc.

Principal Spectrum Preferred Securities Active ETF

PRECIPITATE GOLD CORP by Precipitate Gold Corp

Precipitate Gold Corp

PARTNERRE PFD SHS SER J by PartnerRe Ltd.

PartnerRe Ltd

PRAIRIESKY ROYALTY LTD by Prairiesky Royalty Ltd.

PrairieSky Royalty Ltd

PERPETUAL RES LTD ORD by Perpetual Resources Limited

Perpetual Resources Ltd

Pennsylvania Real Estate Investment Trust

Pennsylvania Real Estate Investment Trust 7 3/8 % Cum Red Perp Pfd Shs Series -B-

Pennsylvania Real Estate Investment Trust 7.20% Cum Red Perp Registered Pfd Shs Series -C-

Pennsylvania Real Estate Investment Trust 6.875% Cum Red Perp Pfd Shs Series -D-

Prosperity Real Estate Investment Trust

POWER RESOURCE EXPL INC by Power Resource Exploration Inc.

Power Resource Exploration Inc

Invesco RAFI US 1000 ETF

PIMCO U.S. Treasury Index Fund PIMCO Preferred and Capital Securities Active Exchange-Traded Fund

PERFICIENT INC COM

PROSPEROUS FUTURE HLDGS by PROSPEROUS FUTURE HLDGS LTD.

Prosperous Future Holdings Ltd

PainReform Ltd

Invesco RAFI US 1500 Small-Mid ETF

PROG Holdings Inc

PUREGOLD PRICE CLUB ADR by Puregold Price Club Inc.

Puregold Price Club Inc

PARAGON SHIPPING CL A ORD by Paragon Shipping, Inc.

Paragon Shipping Inc

Perrigo Co PLC

Progress Software Corporation - Common Stock

Progress Software Corp

Prudential Financial, Inc. 5.950% Junior Subordinated Notes due 2062

PREMIER HEALTH AMER INC by PREMIER HEALTH AMER INC.

PURE H2O BIO-TECHS by Pure H2O Bio-Technologies Inc.

Pure H2O Bio-Technologies Inc

Primerica Inc

Prime Impact Acquisition I Ordinary Shares - Class A

PRIORITY INCOME FD STIRA by Priority Income Fund Inc.

Priority Income Fund, Inc.

Priority Income Fund, Inc. 7.00% Series D Term Preferred Stock due 2029

Priority Income Fund, Inc. 6.625% Series F Term Preferred Stock due 2027

Priority Income Fund, Inc. 6.25% PRF REDEEM 30/06/2026 USD 25 - Ser G

Priority Income Fund, Inc. 6.125% Series I Term Preferred Stock due 2028

Priority Income Fund, Inc. 6.000% Series J Term Preferred Stock due 2028

Priority Income Fund, Inc. 7.000% Series K Cumulative Preferred Stock

Priority Income Fund, Inc. 6.375% Series L Term Preferred Stock Due 2029

Primoris Services Corporation Common Stock

Primoris Services Corp

Prime - United States Dollar

Prism

SPDR SSGA IG Public & Private Credit ETF

Prime Impact Acquisition I Warrants (01/10/2030)

Park National Corp

PARKS! AMERICA INC by Parks! America, Inc.

Parks! America Inc

PARKER CORP by Parker Corp.

Perk International Inc

Parkervision Inc

United Parks & Resorts Inc

PARKVIDA GROUP INC by ParkVida Group, Inc.

ParkVida Group Inc

Parkway Life Real Estate Investment Trust

Proto Labs Inc

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics Inc

Pillarstone Capital REIT

Pillarstone Capital REIT 9.50% PRF PERPETUAL USD 10 - Cls A9.50% PRF PERPETUAL USD 10 - Cls A

PILLARSTONE CAPITAL REIT by Pillarstone Capital REIT

Pearl Holdings Acquisition Corp Ordinary Shares - Class A

Pearl Holdings Acquisition Corp

Pearl Holdings Acquisition Corp Units (1 Ord Share Class A & 1/2 War)

Pearl Holdings Acquisition Corp Warrants (15/12/2026)

PIRELLI & C SPA UNSP/ADR by Pirelli & C. SpA

Pirelli & C SpA

PROLOGIC MGMT SYSTEMS INC by Prologic Management Systems, Inc.

Prologic Management Systems Inc

Propel Holdings Inc

PILLARSTONE CPTL REIT PFD by Pillarstone Capital REIT

Ultra Clean Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) is looking for Q2 Adj EPS of $0.17-$0.37 vs $0.39 analyst estimate. sees sales of $475.000 million-$525.000 million vs $529.38 million analyst estimate.

Guidance

UCTT

Ultra Clean Hldgs Sees Q2 Adj EPS $0.17-$0.37 vs $0.39 Est; Sees Sales $475.000M-$525.000M vs $529.38M Est

Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) is looking for Q2 GAAP EPS of $(0.04)-$(0.01) vs $0.02 analyst estimate. sees sales of $120.000 million-$135.000 million vs $137.59 million analyst estimate.

HLIT

Harmonic Sees Q2 GAAP EPS $(0.04)-$(0.01) vs $0.02 Est; Sees Sales $120.000M-$135.000M vs $137.59M Est

Teledyne Technologies Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) ("Teledyne") announced today that Teledyne's Board of Directors named George C. Bobb III as Teledyne's President and Chief Executive Officer, effective immediately. Simultaneously, Edwin Roks has retired as Teledyne's Chief Executive Officer, but will continue as a special advisor to Robert Mehrabian, Executive Chairman, through August 31, 2025.

Management

Teledyne Technologies Names George Bobb III President And CEO, Effective Immediately

Crown Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) is looking for Q2 Adj EPS of $1.80-$1.90 vs $1.81 analyst estimate..

Crown Holdings Sees Q2 Adj EPS $1.80-$1.90 vs $1.81 Est

Merchants Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIN#NASDAQ">MBIN</a>) reported quarterly earnings of $0.98 per share which missed the analyst consensus estimate of $1.25 by 21.6 percent. This is a 45.56 percent decrease over earnings of $1.80 per share from the same period last year. The company reported quarterly sales of $145.89 million which missed the analyst consensus estimate of $168.50 million by 13.42 percent. This is a 13.13 percent decrease over sales of $167.93 million the same period last year.

Earnings

Earnings Misses

MBIN

Merchants Bancorp Q1 Adj. EPS $0.98 Misses $1.25 Estimate, Sales $145.89M Miss $168.50M Estimate

Crown Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) raises FY2025 Adj EPS guidance from $6.60-$7.00 to $6.70-$7.10 vs $6.80 analyst estimate..

Crown Holdings Raises FY2025 Adj EPS Guidance from $6.60-$7.00 to $6.70-$7.10 vs $6.80 Est

Cincinnati Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CINF#NASDAQ">CINF</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.62) by 61.29 percent. This is a 113.95 percent decrease over earnings of $1.72 per share from the same period last year.

Earnings Beats

CINF

Cincinnati Financial Q1 Adj. EPS $(0.24) Beats $(0.62) Estimate

EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.31 by 9.68 percent. This is a 21.43 percent increase over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $306.32 million which missed the analyst consensus estimate of $310.35 million by 1.30 percent. This is a 7.24 percent increase over sales of $285.64 million the same period last year.

EZPW

EZCORP Q2 Adj. EPS $0.34 Beats $0.31 Estimate, Sales $306.32M Miss $310.35M Estimate

Brixmor Property Group Q1 FFO $0.56 Beats $0.55 Estimate, Sales $337.51M Beat $330.03M Estimate

Noble Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>) affirms FY2025 sales outlook from $3.25 billion-$3.45 billion to $3.25 billion-$3.45 billion vs $3.53 billion estimate.

Noble Corp Affirms FY2025 Sales Guidance of $3.25B-$3.45B vs $3.53B Est

FWRG

First Watch Acquires 16 Franchise Restaurants In North And South Carolina For $49M

Ultra Clean Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) reported quarterly earnings of $0.28 per share which missed the analyst consensus estimate of $0.31 by 9.68 percent. This is a 3.7 percent increase over earnings of $0.27 per share from the same period last year. The company reported quarterly sales of $518.60 million which missed the analyst consensus estimate of $526.13 million by 1.43 percent. This is a 8.56 percent increase over sales of $477.70 million the same period last year.

Ultra Clean Hldgs Q1 Adj. EPS $0.28 Misses $0.31 Estimate, Sales $518.60M Miss $526.13M Estimate

Northwest Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWBI#NASDAQ">NWBI</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.24 by 45.83 percent. This is a 52.17 percent increase over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $127.82 million which beat the analyst consensus estimate of $112.32 million by 13.80 percent. This is a 23.81 percent increase over sales of $103.24 million the same period last year.

NWBI

Northwest Bancshares Q1 Adj. EPS $0.35 Beats $0.24 Estimate, Sales $127.82M Beat $112.32M Estimate

Rambus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.50 by 12 percent. This is a 24.44 percent increase over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $166.66 million which beat the analyst consensus estimate of $162.86 million by 2.34 percent. This is a 24.76 percent increase over sales of $133.59 million the same period last year.

RMBS

Rambus Q1 GAAP EPS $0.56 Beats $0.50 Estimate, Sales $166.66M Beat $162.86M Estimate

Crown Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) reported quarterly earnings of $1.67 per share which beat the analyst consensus estimate of $1.23 by 35.77 percent. This is a 63.73 percent increase over earnings of $1.02 per share from the same period last year. The company reported quarterly sales of $2.89 billion which beat the analyst consensus estimate of $2.82 billion by 2.42 percent. This is a 3.70 percent increase over sales of $2.78 billion the same period last year.

Crown Holdings Q1 Adj. EPS $1.67 Beats $1.23 Estimate, Sales $2.89B Beat $2.82B Estimate

Noble Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.57 by 54.39 percent. This is a 42.22 percent decrease over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $874.49 million which beat the analyst consensus estimate of $873.87 million by 0.07 percent. This is a 37.26 percent increase over sales of $637.08 million the same period last year.

Noble Corp Q1 Adj. EPS $0.26 Misses $0.57 Estimate, Sales $874.49M Beat $873.87M Estimate

HomeStreet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HMST#NASDAQ">HMST</a>) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.07) by 114.29 percent. This is a 48.28 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $45.36 million which missed the analyst consensus estimate of $46.61 million by 2.69 percent. This is a 9.02 percent increase over sales of $41.60 million the same period last year.

HMST

HomeStreet Q1 Adj. EPS $(0.15) Misses $(0.07) Estimate, Sales $45.36M Miss $46.61M Estimate

Netstreit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTST#NYSE">NTST</a>) raises FY2025 FFO guidance from $1.27-$1.30 to $1.28-$1.30 vs $1.28 analyst estimate..

NTST

Netstreit Raises FY2025 FFO Guidance from $1.27-$1.30 to $1.28-$1.30 vs $1.28 Est

F5 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) reported quarterly earnings of $3.42 per share which beat the analyst consensus estimate of $3.10 by 10.32 percent. This is a 17.53 percent increase over earnings of $2.91 per share from the same period last year. The company reported quarterly sales of $731.12 million which beat the analyst consensus estimate of $718.89 million by 1.70 percent. This is a 7.30 percent increase over sales of $681.35 million the same period last year.

FFIV

F5 Q2 Adj. EPS $3.42 Beats $3.10 Estimate, Sales $731.12M Beat $718.89M Estimate

Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRO#NASDAQ">STRO</a>), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced poster presentations at the upcoming 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30 in Chicago, IL. The presentations will cover preclinical activity and safety data for STRO-004, the Company's novel exatecan Tissue Factor ADC, as well as showcase the unique advantages of Sutro's XpressCF+&#xAE; platform in enabling precise and efficient development of dual-payload ADCs.
"We are excited to share our progress advancing our next-generation ADC pipeline at AACR," said Jane Chung, Sutro's Chief Executive Officer. "In preclinical studies, STRO-004 consistently demonstrated potent, dose-dependent anti-tumor activity and a favorable safety profile across all tested doses. Of note, STRO-004, after only a single dose, achieved promising overall response and disease control rates in Tissue Factor-positive patient-derived xenograft models spanning multiple cancer types. We look forward to continuing to investigate the full potential of STRO-004, as we complete IND-enabling studies and prepare to initiate a first-in-human trial later this year."
Ms. Chung continued: "Also, as presented at AACR, our XpressCF+&#xAE; cell-free platform is uniquely capable of creating revolutionary dual-payload ADCs—differentiated by higher drug-to-antibody ratios, fully site-selective conjugation of two linker payloads and a validated, cell-free ADC manufacturing process. We are excited to showcase these and other key features of our platform, which enable our ADC candidates to overcome limitations of conventional ADCs and the challenges of targeting complex disease biology. These presentations further reinforce our technology leadership and our highly differentiated ADC candidates."

Biotech

General

STRO

Sutro Biopharma Announces Poster Presentations To Highlight Its Next-Generation Exatecan And Dual-Payload ADC Programs At Upcoming American Association for Cancer Research April 25-30 In Chicago, Illinois

Comments

Permian Resources

Permian Resources (PR) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL